Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  KOREA EXCHANGE  >  Samsung Biologics Co Ltd    A207940   KR7207940008

SAMSUNG BIOLOGICS CO LTD

(A207940)
  Report  
 SummaryNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Financials (KRW)
Sales 2019 575 B
EBIT 2019 38,2 B
Net income 2019 26,5 B
Finance 2019 207 B
Yield 2019 -
Sales 2020 854 B
EBIT 2020 188 B
Net income 2020 202 B
Finance 2020 254 B
Yield 2020 -
P/E ratio 2019 848x
P/E ratio 2020 120x
EV / Sales2019 39 577x
EV / Sales2020 26 654x
Capitalization 22 761 B
More Financials
Company
SAMSUNG BIOLOGICS Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of biological products. The Company, a contract manufacturing organization (CMO) mainly develops, manufactures antibody drugs, which are used for the treatment of cancer, autoimmune... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Samsung Biologics Co Ltd
Trading Rating : Investor Rating :
More Ratings
Latest news on SAMSUNG BIOLOGICS CO LTD
08/29South Korea court ruling raises chance of Samsung heir's return to jail
RE
08/29SAMSUNG ELECTRONICS : South Korea's top court ruling on Samsung heir and ex-pres..
RE
08/22SAMSUNG ELECTRONICS : South Korea's top court to rule on Samsung heir's bribery ..
RE
08/22SAMSUNG ELECTRONICS : South Korea's top court to rule on Samsung heir's bribery ..
RE
07/24Samsung Biologics, Biogen Venture Gets FDA OK for Humira Biosimilar
DJ
06/24SAMSUNG ELECTRONICS : embroiled in multiple patent lawsuits in US
AQ
06/17Samsung scrambles to deal with growing uncertainties
AQ
06/14SAMSUNG ELECTRONICS : president grilled amid biotech accounting scandal
AQ
06/12SAMSUNG ELECTRONICS : president grilled about accounting scandal at biotech affi..
AQ
06/12SAMSUNG ELECTRONICS : president grilled about accounting scandal at biotech affi..
AQ
06/12SAMSUNG ELECTRONICS : Prosecution summons Samsung exec over alleged role in biot..
AQ
06/12SAMSUNG ELECTRONICS : Prosecution summons Samsung exec over alleged role in biot..
AQ
05/27SAMSUNG BIOLOGICS : S Korea arrest warrants approved in Samsung accounting scand..
AQ
05/27SAMSUNG BIOLOGICS : Court rejects arrest warrant for Samsung BioLogics CEO
AQ
05/24SAMSUNG ELECTRONICS : South Korea orders further arrests at Samsung Electronics ..
RE
More news
News in other languages on SAMSUNG BIOLOGICS CO LTD
2018Samsung veut investir 19 milliards d'euros dans les nouvelles technologies
2018Bilanzierungsverstöße bei Samsung-Tochter - Aktie bricht ein
2017Boehringer erhält Zulassung für Kopie von Kassenschlager Humira
More news
Analyst Recommendations on SAMSUNG BIOLOGICS CO LTD
More recommendations
Sector news : Biopharmaceuticals
02:48aNovartis Lauds Launch of Pricey Gene Therapy -- WSJ
DJ
02:47aP&G Adds To Streak Of Sales Increases -- WSJ
DJ
01:45aBiogen, Eisai revive plans for Alzheimer's drug, surprising market
RE
10/22AMGEN : CFO David Meline to Retire; Peter H. Griffith to Be Next CFO
DJ
10/22BIOGEN : Reversing Itself, to Seek FDA OK for Alzheimer's Drug -- 5th Update
DJ
More sector news : Biopharmaceuticals
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 344 000,00  
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Tae-Han Kim Chief Executive Officer & Director
Ho-Yeol Yoon Managing Director & Head-Operations Support
Dong-Joong Kim Director & Head-Management Support
Seok-Woo Jung Independent Director
Byeong-Cheol Yoon Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SAMSUNG BIOLOGICS CO LTD19 419
CSL LIMITED35.42%78 131
BIOGEN INC.-6.33%51 990
ALEXION PHARMACEUTICALS3.46%22 261
GRIFOLS18.65%18 234
WUXI BIOLOGICS CAYMAN INC--.--%13 051